Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.76 CHF | -2.88% | -1.76% | +124.07% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
Sales 2022 | 17.99M 19.66M | Sales 2023 | 33.56M 36.68M | Capitalization | 128M 140M |
---|---|---|---|---|---|
Net income 2022 | -14M -15.3M | Net income 2023 | -13M -14.21M | EV / Sales 2022 | 1.76 x |
Net cash position 2022 | 22.08M 24.13M | Net cash position 2023 | 12M 13.11M | EV / Sales 2023 | 3.46 x |
P/E ratio 2022 |
-3.41
x | P/E ratio 2023 |
-9.18
x | Employees | 80 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.77% |
1 day | -1.81% | ||
1 week | -1.26% | ||
Current month | +21.30% | ||
1 month | +16.79% | ||
3 months | +43.43% | ||
6 months | +108.49% | ||
Current year | +125.21% |
Managers | Title | Age | Since |
---|---|---|---|
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 23-02-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott P. Bruder
BRD | Director/Board Member | 62 | 18-06-13 |
Christopher Fair
CEO | Chief Executive Officer | 54 | 21-04-18 |
Joost de Bruijn
FOU | Founder | 58 | 17-12-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 7.82 | -2.13% | 8 546 |
24-05-23 | 7.99 | +0.50% | 118,615 |
24-05-22 | 7.95 | +1.92% | 86,555 |
24-05-21 | 7.8 | -2.01% | 131,797 |
24-05-17 | 7.96 | -1.49% | 291,041 |
Delayed Quote Swiss Exchange, May 24, 2024 at 03:13 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+125.21% | 322M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.03% | 21.58B | |
-8.96% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- KURN Stock